Focus Stocks
JNJ Setting for a Break Out?
Published on Wednesday, 03 March 2010 07:04 Written by TradersHuddle Staff
New York, March 3rd (TradersHuddle.com) - Shares of Johnson and Johnson (NYSE:JNJ) closed the trading session at $63.44 near its 50 day and 200 day moving averages currently set at $63.87 and $60.72 respectively. JNJ's price action is above the 200 day moving average but below its 50 day moving average, signaling a possible break out.
Johnson & Johnson (NYSE:JNJ) manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, Tylenol, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. The consumer healthcare products company was founded in 1886 and is based in New Brunswick, NJ.
A tiered approach to enter the stock, appears to be the best way to maximize possible movements from the stock, as traders could enter JNJ with a small position and wait for the stock to break out above the 50 day moving average at $63.87, where traders could add to their position as momentum builds with the breakout. The flip side will be if support being referenced at the 200 day moving average set at $60.72 breaks it could mean further downside in the horizon for JNJ.
Related Articles
- Biosense Webster Announces Launch of the THERMOCOOL® SF NAV Catheter With Curve Visualization
- Biosense Webster Collaborates to Bring Innovative Solutions to Electrophysiologists Around the World
- Leading Authority On Eye Allergies Shares Tips, Offers Advice For Eye Allergy Sufferers On New Edition Of Healthy Vision™ With Dr. Val Jones
- Johnson & Johnson to Participate in 2012 Deutsche Bank Securities, Inc. 37th Annual Health Care Conference
- Johnson & Johnson Holds 2012 Annual Meeting of Shareholders
- Johnson & Johnson Announces Dividend Increase of 7.0%
- Johnson & Johnson to Webcast Annual Meeting of Shareholders
- Market Soars as Earnings Season Begins
- Dow Jones Round Up - Higher: KO, HPQ, CVX
- Johnson & Johnson Reports 2012 First-Quarter Results:
Related Partner Headlines
- Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow - TheStreet.com
- Johnson & Johnson (JNJ): Today's Featured Drugs Loser - TheStreet.com
- Johnson & Johnson Remains Too Big to Succeed - TheStreet.com
- Johnson & Johnson (JNJ): Today's Featured Drugs Loser - TheStreet.com
- Two Pharmaceutical Plays to Consider - TheStreet.com
- Johnson & Johnson Announces Dividend Increase of 7.0% to $0.61 - Benzinga
- Johnson & Johnson (JNJ): Today's Featured Drugs Winner - TheStreet.com
- 3 Cancer-Drug Stocks Look Strong - TheStreet.com
- Johnson & Johnson Profit Beats, Sales Slip 2.4% - TheStreet.com
- Johnson & Johnson Stock Upgraded (JNJ) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Stocks To Watch For May 25 - Benzinga -
Top 4 Stocks In The Specialty Eateries Industry With The Highest Cash - Benzinga -
Top 4 Small-Cap Stocks In The Security Software & Services Industry With The Highest ROE - Benzinga -
Top 4 Small-Cap Stocks In The Health Care Plans Industry With The Highest Revenue - Benzinga -
Top 4 Small-Cap Stocks In The Heavy Construction Industry With The Lowest PEG Ratio - Benzinga -
Earnings Scheduled For May 25 - Benzinga -
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com -
The Global Retrenchment Accelerates - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis -
Score a Hit With FIFA 13 From Tesco Entertainment Online -
Syngenta settles atrazine litigation in the USA -
Atrazine Litigation Settled -
eMazzanti Attains Xerox Gold Partner Status -
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends









